Salvador, Oscar B.

HRN: 21-91-16  Sex: Male

Patient Encounter


AMS Audit List

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
09/08/2022
METRONIDAZOLE 5MG/ML, 100ML (VIAL)
09/08/2022
09/15/2022
IV
500mg
Q8
T/C Amoebic Hepatic Abscess
Waiting Final Action 
09/09/2022
METRONIDAZOLE 5MG/ML, 100ML (VIAL)
09/09/2022
09/17/2022
IVT
750 Mg
Q8H
Amoebic Abscess
Waiting Final Action 
09/17/2022
METRONIDAZOLE 500MG (TAB)
09/17/2022
09/24/2022
PO
500 Mg
Q8H
Hepatic Abscess R Lobe
Waiting Final Action 

AMS Audit Form


Start Date: End Date:

Indication:

              

Type of Infection:

                             

           

Compliance to guidelines:



Initial appropriateness:



 If inappropriate:

           

Final appropriateness:



 If inappropriate:

              

Overall appropriateness: